---
title: "Hangzhou AGS Medtech Co., Ltd. (688581.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688581.SH.md"
symbol: "688581.SH"
name: "Hangzhou AGS Medtech Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T11:31:55.726Z"
locales:
  - [en](https://longbridge.com/en/quote/688581.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688581.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688581.SH.md)
---

# Hangzhou AGS Medtech Co., Ltd. (688581.SH)

## Company Overview

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generators, endoscopic C02 regulation units, endoscopic water pumps, single use electrosurgical knife combination, and bipolar coagulation forceps; ERCP products, such as disposable guide wires, disposable stone extraction baskets, stone retrieval balloons, and sphincterotome; and disposable endoscope cleaning brushes. The company was incorporated in 2010 and is headquartered in Hangzhou, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.bioags.com](https://www.bioags.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: C (0.49)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 48 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.83% |  |
| Net Profit YoY | -24.76% |  |
| P/B Ratio | 1.95 |  |
| Dividend Ratio | 2.22% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5028763055.38 |  |
| Revenue | 610132320.82 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.89% | B |
| Profit Margin | 36.67% | A |
| Gross Margin | 69.40% | A |
| Revenue YoY | -6.83% | D |
| Net Profit YoY | -24.76% | D |
| Total Assets YoY | 5.54% | C |
| Net Assets YoY | 4.76% | C |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | -6.83% | D |
| Turnover | 0.23 | D |
| Gearing Ratio | 4.72% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Hangzhou AGS Medtech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-6.83%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-24.76%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.95",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.22%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5028763055.38",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "610132320.82",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.89%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "36.67%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "69.40%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-6.83%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-24.76%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.54%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.76%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-6.83%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.23",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "4.72%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 22.59 | 5/64 | 20.52 | 18.18 | 17.38 |
| PB | 1.95 | 13/64 | 2.44 | 2.05 | 1.91 |
| PS (TTM) | 8.29 | 40/64 | 8.78 | 7.80 | 7.14 |
| Dividend Yield | 2.21% | 12/64 | 2.33% | 2.18% | 1.79% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-08-18T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 60.99 |
| Highest Target | 100.00 |
| Lowest Target | 100.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688581.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688581.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688581.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**